Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,769Revenue (TTM) $M16,309Net Margin (%)10.1Altman Z-Score0.8
Enterprise Value $M25,176EPS (TTM) $1.3Operating Margin %16.2Piotroski F-Score5
P/E(ttm)27.4Beneish M-Score-2.1Pre-tax Margin (%)13.5Higher ROA y-yN
Price/Book0.910-y EBITDA Growth Rate %11.7Quick Ratio0.6Cash flow > EarningsY
Price/Sales1.35-y EBITDA Growth Rate %6.7Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow9.9y-y EBITDA Growth Rate %198ROA % (ttm)4.1Higher Current Ratio y-yN
Dividend Yield %1.2PEG4.2ROE % (ttm)11.4Less Shares Outstanding y-yY
Payout Ratio %31.0Shares Outstanding M388ROIC % (ttm)7.9Gross Margin Increase y-yN

Gurus Latest Trades with MKGAY

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

MKGAY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


MKGAY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about MKGAY:

    News about MKGAY:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Frosty-brilliant Silver Shine: The Merck Pigment Innovation Ronastar® Frozen Jewel Nov 22 2016
    Merck KGaA :MKGAY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016 Nov 17 2016
    Merck Raises Profit Forecast for 2016 Following Good Third Quarter Nov 16 2016
    Germany's Merck Lifts Full-Year Guidance After Sigma-Aldrich Boosts Sales Nov 15 2016
    Merck KGaA, Darmstadt, Germany's Phase IIb ADDRESS II Results Confirm Potential of Atacicept as a... Nov 14 2016
    European Stock Markets Rally After Early Morning Bloodbath, Trump Concerns Ease Nov 09 2016
    Merck Invests € 250 Million in Production Value Chain in China Nov 07 2016
    Merck KGaA, Darmstadt, Germany, Presents Phase II Data on the Safety and Efficacy of Atacicept at... Nov 02 2016
    Merck KGaA, Darmstadt, Germany, Presents Phase II Data on the Safety and Efficacy of Atacicept at... Nov 02 2016
    Merck KGaA, Darmstadt, Germany Partners with American Cancer Society to Address Cancer in Women Nov 01 2016
    European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the... Oct 31 2016
    European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the... Oct 31 2016
    Merck Showcases Innovative Effect Pigments and Processes at K2016 Oct 18 2016
    Merck Expands Biotech Production Capacity in Spain Oct 17 2016
    Merck Grants Rights to tutoProm™ Surface Coatings to durXtreme Oct 17 2016
    CHMP Adopts Positive Opinion of Metformin, Including Merck’s Type 2 Diabetes Treatment Portfolio,... Oct 14 2016
    Merck Introduces First Certified Spiking Solution® of Heavy Labeled Thyroglobulin Protein Oct 13 2016
    Merck Sets its Sights on 2018 and Outlines Future Strategic Roadmap Oct 13 2016
    Merck Publishes First International Curiosity Study Oct 12 2016
    Merck KGaA, Darmstadt, Germany, Announces Recipients of Third Annual €1 Million 'Grant for... Oct 10 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)